423 related articles for article (PubMed ID: 12399544)
1. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.
Zhao H; Watkins JL; Piwnica-Worms H
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14795-800. PubMed ID: 12399544
[TBL] [Abstract][Full Text] [Related]
2. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
[TBL] [Abstract][Full Text] [Related]
3. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
[TBL] [Abstract][Full Text] [Related]
4. NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint.
Melixetian M; Klein DK; Sørensen CS; Helin K
Nat Cell Biol; 2009 Oct; 11(10):1247-53. PubMed ID: 19734889
[TBL] [Abstract][Full Text] [Related]
5. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
7. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
Jin J; Ang XL; Ye X; Livingstone M; Harper JW
J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
[TBL] [Abstract][Full Text] [Related]
8. Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.
Yan Y; Black CP; Cowan KH
Oncogene; 2007 Jul; 26(32):4689-98. PubMed ID: 17297454
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells.
Koniaras K; Cuddihy AR; Christopoulos H; Hogg A; O'Connell MJ
Oncogene; 2001 Nov; 20(51):7453-63. PubMed ID: 11709716
[TBL] [Abstract][Full Text] [Related]
10. Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1.
Park HU; Jeong JH; Chung JH; Brady JN
Oncogene; 2004 Jun; 23(29):4966-74. PubMed ID: 15107832
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
12. The regulatory beta-subunit of protein kinase CK2 accelerates the degradation of CDC25A phosphatase through the checkpoint kinase Chk1.
Kreutzer J; Guerra B
Int J Oncol; 2007 Nov; 31(5):1251-9. PubMed ID: 17912454
[TBL] [Abstract][Full Text] [Related]
13. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
14. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
Sørensen CS; Syljuåsen RG; Lukas J; Bartek J
Cell Cycle; 2004 Jul; 3(7):941-5. PubMed ID: 15190204
[TBL] [Abstract][Full Text] [Related]
15. The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.
Zhang Y; Qu D; Morris EJ; O'Hare MJ; Callaghan SM; Slack RS; Geller HM; Park DS
J Neurosci; 2006 Aug; 26(34):8819-28. PubMed ID: 16928871
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
Agner J; Falck J; Lukas J; Bartek J
Exp Cell Res; 2005 Jan; 302(2):162-9. PubMed ID: 15561098
[TBL] [Abstract][Full Text] [Related]
17. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
[TBL] [Abstract][Full Text] [Related]
18. [Degradation of Cdc25A phosphatase in HeLa cells under normal and stress conditions].
Goloudina AR; Aksenov ND; Pospelov VA
Tsitologiia; 2004; 46(5):423-30. PubMed ID: 15344887
[TBL] [Abstract][Full Text] [Related]
19. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability.
Collis SJ; Barber LJ; Clark AJ; Martin JS; Ward JD; Boulton SJ
Nat Cell Biol; 2007 Apr; 9(4):391-401. PubMed ID: 17384638
[TBL] [Abstract][Full Text] [Related]
20. Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression.
Goto H; Natsume T; Kanemaki MT; Kaito A; Wang S; Gabazza EC; Inagaki M; Mizoguchi A
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30635443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
